date:Nov 14, 2012
ng this product to market to the benefit of farmers and consumers.
We are very pleased that Ceapro and AAFC have signed this new oat variety agreement to become the feedstock for utilizing both AAFCs and Ceapros unique and innovative process technologies to produce high concentration and high yield avenanthramide products, said Gilles Gagnon, Ceapros President and Chief Executive Officer. The commercial development of these avenanthramide products should allow Ceapro to enter the functional foo